Gland Pharma Limited IPO

Mainboard

Pharmaceuticals & Drugs

Listed On: Nov 20, 2020 at ₹ 1710.0

Exp. Premium: 50 (3.33%)

₹ 15000 /10 Shares

*Expected Premium provided in this app is derived from market rumors. It is not a guaranteed indicator of the actual listing price and should be interpreted with caution.

Price Summary

Last Closing

1,811.00 (20.73%)

52 Week High

2,220.95

52 Week Low

1,475.05

Last Update

20-Sep-2024 3:30 PM

IPO Live Subscription Details

Date

2020-11-11 17:00:00

QIBs

6.40

NII

0.51

Retail

0.24x

Total

2.06 times

IPO Details

09 Nov, 2020

Open Date

11 Nov, 2020

Close Date

18 Nov, 2020

Allotment Date

20 Nov, 2020

Listing Date

Issue Price

₹1490 - 1500 per equity share

Face Value

₹1 Per Equity Share

Listing at Group

BSE, NSE

Registrar

Link Intime India Private Ltd

List Price

1710.0

Listing Date

2020-11-20

Market Lot

10 Shares (₹15000/-)

Lead Manager

Citigroup Global Markets India Private Limited
Haitong Securities India Private Limited
Kotak Mahindra Capital Company Limited
Nomura Financial Advisory And Securities (India) Pvt Ltd

Issue Size

43,196,968 Eq Shares of ₹1 (aggregating up to ₹6,479.55 Cr)

Fresh Issue:8,333,333 Eq Shares of ₹1 (aggregating up to ₹1,250.00 Cr)

Offer for Sale: 34,863,635 Eq Shares of ₹1 (aggregating up to ₹5,229.55 Cr)

Retail Portion

N/A

Subscription

2.06 times

IPO Docs

DRHP RHP

IPO Subscription Details

As on	QIB	NII	Retail	Total
Shares Offered / Reserved	8,639,394	6,479,546	15,118,939	27,350,957
Day 1 - 09-11-20 05:00 PM	0.00 x	0.01	0.08 x	0.05 x
Day 2 - 10-11-20 05:00 PM	0.48 x	0.03	0.15 x	0.22 x
Day 3 - 11-11-20 06:00 PM	6.40 x	0.51	0.24 x	2.06 x

Valuations

Earnings Per Share (EPS)

N/A

P/E Ratio

N/A

RoNW

N/A

Net Asset Value (NAV) - Post Issue

N/A

Company Financials All values are in ₹ Cr.

	31-Mar-20	31-Mar-19	31-Mar-18
Assets	4,086.03	3,523.54	2.929.46
Revenue	2,772.40	2,129.76	1,671.68
Profit After Tax	772.85	451.85	321.05

About The Company

Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets.

They operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped them witness exponential growth.

They are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.

Axis Capital	None
Capital Market	Other
Dalal Street Investment Journal	Subscribe
GEPL Capital Ltd	Subscribe
ICICI Direct	Subscribe
Kotak Securities	Other
KR Choksey Securities Ltd	Subscribe
S P Tulsian	Subscribe

- Promoter(s)

Company Promoter(s)

Fosun Pharma Industrial Pte. Ltd
Shanghai Fosun Pharmaceutical (Group) Co. Ltd

IPO - Issue Objectives

To finance the incremental working capital requirements of our Company
To meet funding requirements for capital expenditure requirements
To meet the general corporate purposes

IPO - FAQs

Ans. Gland Pharma Limited IPO is a Mainboard IPO. The issue is priced at ₹1490 - 1500 per equity share. The minimum order quantity is 10 Shares. The IPO opens on Nov 9, 2020, and closes on Nov 11, 2020. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Ans. The Gland Pharma Limited IPO opens on Nov 9, 2020 and closes on Nov 11, 2020.

Ans. The size of Gland Pharma Limited IPO is 43,196,968 Eq Shares of ₹1 (aggregating up to ₹6,479.55 Cr) Fresh Issue:8,333,333 Eq Shares of ₹1 (aggregating up to ₹1,250.00 Cr) Offer for Sale: 34,863,635 Eq Shares of ₹1 (aggregating up to ₹5,229.55 Cr).

Ans. The IPO price band is set between ₹1490 - 1500 per equity share.

Ans. To apply for Gland Pharma Limited IPO IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Gland Pharma Limited IPO in the List of IPOs
- Press "Apply" Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Gland Pharma Limited IPO is Nov 18, 2020.

Ans. The Gland Pharma Limited IPO will be listed on Nov 20, 2020.

Ans. Follow the steps to check the allotment status for Gland Pharma Limited IPO here.